Squarepoint’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Buy
856,569
+458,540
+115% +$789K ﹤0.01% 1305
2025
Q1
$1.33M Buy
398,029
+245,687
+161% +$818K ﹤0.01% 1364
2024
Q4
$1.13M Sell
152,342
-155,042
-50% -$1.15M ﹤0.01% 1459
2024
Q3
$2.89M Buy
307,384
+49,841
+19% +$468K ﹤0.01% 970
2024
Q2
$2.07M Buy
+257,543
New +$2.07M ﹤0.01% 1059
2023
Q4
Sell
-128,541
Closed -$585K 2728
2023
Q3
$585K Buy
+128,541
New +$585K ﹤0.01% 1546
2023
Q2
Sell
-41,632
Closed -$254K 2610
2023
Q1
$254K Buy
+41,632
New +$254K ﹤0.01% 1755
2022
Q4
Sell
-368,310
Closed -$3.53M 2449
2022
Q3
$3.53M Buy
+368,310
New +$3.53M 0.02% 567
2022
Q2
Sell
-21,546
Closed -$359K 2362
2022
Q1
$359K Sell
21,546
-102,045
-83% -$1.7M ﹤0.01% 1646
2021
Q4
$2.36M Buy
123,591
+90,730
+276% +$1.73M 0.01% 787
2021
Q3
$810K Buy
32,861
+9,727
+42% +$240K ﹤0.01% 1171
2021
Q2
$602K Sell
23,134
-13,093
-36% -$341K ﹤0.01% 1499
2021
Q1
$1.15M Buy
+36,227
New +$1.15M 0.01% 995
2020
Q4
Sell
-12,640
Closed -$416K 2698
2020
Q3
$416K Sell
12,640
-119,130
-90% -$3.92M 0.01% 1473
2020
Q2
$3.62M Buy
131,770
+124,960
+1,835% +$3.43M 0.06% 439
2020
Q1
$204K Sell
6,810
-43,510
-86% -$1.3M 0.01% 1466
2019
Q4
$1.39M Buy
50,320
+15,592
+45% +$432K 0.01% 1103
2019
Q3
$632K Sell
34,728
-19,787
-36% -$360K 0.01% 1450
2019
Q2
$1.34M Sell
54,515
-282,112
-84% -$6.92M 0.01% 1076
2019
Q1
$3.2M Buy
336,627
+120,175
+56% +$1.14M 0.03% 584
2018
Q4
$1.92M Sell
216,452
-36,548
-14% -$324K 0.02% 680
2018
Q3
$2.85M Buy
253,000
+109,000
+76% +$1.23M 0.03% 591
2018
Q2
$1.84M Buy
144,000
+37,500
+35% +$480K 0.02% 663
2018
Q1
$1.8M Buy
106,500
+92,554
+664% +$1.56M 0.03% 607
2017
Q4
$112K Sell
13,946
-29,260
-68% -$235K ﹤0.01% 1924
2017
Q3
$335K Buy
+43,206
New +$335K 0.01% 1114